Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Programmed cell death protein 1 (Homo sapiens) | BDBM482344![]() (US10919852, Compound TABLE 1.43) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482345![]() (US10919852, Compound TABLE 1.44 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482346![]() (US10919852, Compound TABLE 1.45 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482347![]() (US10919852, Compound TABLE 1.46 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482352![]() (US10919852, Compound TABLE 1.51 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482353![]() (US10919852, Compound TABLE 1.52 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482354![]() (US10919852, Compound TABLE 1.53 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482355![]() (US10919852, Compound TABLE 1.54 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482356![]() (US10919852, Compound TABLE 1.55 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482357![]() (US10919852, Compound TABLE 1.56 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482358![]() (US10919852, Compound TABLE 1.57 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482359![]() (US10919852, Compound TABLE 1.58 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482360![]() (US10919852, Compound TABLE 1.59 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482361![]() (US10919852, Compound TABLE 1.60 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482362![]() (US10919852, Compound TABLE 1.61 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482363![]() (US10919852, Compound TABLE 1.62 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482365![]() (US10919852, Compound TABLE 1.64 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482366![]() (US10919852, Compound TABLE 1.65 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482367![]() (US10919852, Compound TABLE 1.66 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482368![]() (US10919852, Compound TABLE 1.67 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482369![]() (US10919852, Compound TABLE 1.68 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482370![]() (US10919852, Compound TABLE 1.69 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482371![]() (US10919852, Compound TABLE 1.70 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482372![]() (US10919852, Compound TABLE 1.71 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482373![]() (US10919852, Compound TABLE 1.72 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482374![]() (US10919852, Compound TABLE 1.73 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482375![]() (US10919852, Compound TABLE 1.74 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482376![]() (US10919852, Compound TABLE 1.75 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482377![]() (US10919852, Compound TABLE 1.76 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482378![]() (US10919852, Compound TABLE 1.77 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482379![]() (US10919852, Compound TABLE 1.78 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482381![]() (US10919852, Compound TABLE 1.80 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482382![]() (US10919852, Compound TABLE 1.81 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482383![]() (US10919852, Compound TABLE 1.82 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482384![]() (US10919852, Compound TABLE 1.83 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482385![]() (US10919852, Compound TABLE 1.84 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482386![]() (US10919852, Compound TABLE 1.85 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482387![]() (US10919852, Compound TABLE 1.86 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482305![]() (US10919852, Compound TABLE 1.4 | US10919852, Compo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482389![]() (US10919852, Compound TABLE 1.88 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482390![]() (US10919852, Compound TABLE 1.89 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482391![]() (US10919852, Compound TABLE 1.90 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482392![]() (US10919852, Compound TABLE 1.91 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482393![]() (US10919852, Compound TABLE 1.92 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482394![]() (US10919852, Compound TABLE 1.93 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482397![]() (US10919852, Compound TABLE 1.96 | US11708326, Comp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482462![]() (US10919852, Compound TABLE 1.161 | US11708326, Com...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482463![]() (US10919852, Compound TABLE 1.162 | US11708326, Com...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482464![]() (US10919852, Compound TABLE 1.163 | US11708326, Com...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death protein 1 (Homo sapiens) | BDBM482465![]() (US10919852, Compound TABLE 1.164 | US11708326, Com...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description 96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W... | US Patent US10919852 (2021) BindingDB Entry DOI: 10.7270/Q2RF5Z3R | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 416 total ) | Next | Last >> |